PDGFRB: Platelet-derived growth factor receptor beta
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Tyrosine-protein kinase that acts as a cell-surface receptor for homodimeric PDGFB and PDGFD and for heterodimers formed by PDGFA and PDGFB, and plays an essential role in the regulation of embryonic development, cell proliferation, survival, differentiation, chemotaxis and migration.
- Drugs that act on it: 17
- With a US drug page: 4
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it. All act as: Platelet-derived growth factor receptor beta inhibitor.| Imatinib | Approved | — | Inhibitor | — |
| Sorafenib | Approved | — | Inhibitor | — |
| Sunitinib | Approved | — | Inhibitor | Boxed warning |
| Tivozanib | Approved | — | Inhibitor | — |
| Catequentinib | — | — | Inhibitor | — |
| CDP-860 | — | — | Inhibitor | — |
| CEP-2563 | — | — | Inhibitor | — |
| CM-082 | — | — | Inhibitor | — |
| Dasatinib anhydrous | — | — | Inhibitor | — |
| JI-101 | — | — | Inhibitor | — |
| PD-0166285 | — | — | Inhibitor | — |
| Puquitinib | — | — | Inhibitor | — |
| RG-1530 | — | — | Inhibitor | — |
| Rinucumab | — | — | Inhibitor | — |
| Tandutinib | — | — | Inhibitor | — |
| Telatinib | — | — | Inhibitor | — |
| TG100-801 | — | — | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Bilateral striopallidodentate calcinosis
- 0.79
- Myofibromatosis, infantile, 1
- 0.76
- Infantile myofibromatosis
- 0.75
- Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
- 0.74
- Acroosteolysis-keloid-like lesions-premature aging syndrome
- 0.74
- Neoplasm
- 0.65
- Non-small cell lung carcinoma
- 0.60
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- PDGFRB
Drugs and mechanisms are from ChEMBL CHEMBL1913 (CC BY-SA 3.0). Gene name, function (UniProt P09619, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets